Nitric oxide nasal spray

Photo: ABP News

Glenmark Launches Nitric Oxide Nasal Spray For COVID-19 Patients In India

Amid COVID-19 pandemic, India is to have Nitric Oxide Nasal Spray, for adults having the infection. Launched on February 9 by Glenmark Pharmaceutical, the spray would be for adults, contracting the virus, with high-risk of progression of the disease. The medicine has been launched under FabiSpray brand in India. In July 2021, Glenmark proposed the nasal Spray, which later got approved by the Drugs Controller Genera of India (DCGI). 

Wed, 09 Feb 2022 - 10:35 AM / by Varsha Joshi

Tags: Covid-19, Nasal Spray, glenmark pharmaceuticals, Central Government, DCGI